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Abstract: Kartagener syndrome (KS) is an autosomal recessive disorder characterized by situs inversus,
paranasal sinusitis and bronchiectasis. We report the successful use of double lung transplant (DLTx) to treat
end-stage KS. A 49-year-old Han woman was admitted to Renmin Hospital (Wuhan University, China) in
September 2017 with a ≥15 year history of chronic productive cough that had worsened during the past year.
Clinical examination and imaging investigations revealed respiratory failure and situs inversus consistent
with KS. The patient was successfully treated with DLTx involving bilateral bronchial anastomoses. DLTx is
a feasible treatment option for end-stage KS.
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Introduction
Kartagener syndrome (KS) is a rare autosomal recessive
disorder with an incidence of 1 per 20,000–30,000 live
births (1). KS is a primary ciliary dyskinesia (PCD)
characterized by situs inversus, paranasal sinusitis and
bronchiectasis (2). Clinical manifestations of KS usually
present during childhood and include chronic rhinitis due to
pansinusitis, cough, wheeze and shortness of breath due to
recurrent respiratory tract infections and bronchiectasis, and
hearing problems due to otitis media (3,4). Recommended
diagnostic investigations for KS include nasal nitric oxide
measurement, ciliary biopsy with electron microscopy,
functional ciliary beat/waveform analysis with high-speed
videomicroscopy, and genetic testing (3).
Routine treatment of KS involves daily chest
physiotherapy for airway clearance, antibiotics for acute
respiratory exacerbations and vaccinations. Therapies
considered on a case-by-case basis include chronic
suppressive antibiotics, inhaled hyperosmolar agents (to
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promote cough clearance) and bronchodilators (3). Lung
transplantation (LTx) is an option for end-stage KS, which
results in respiratory insufficiency (5).
Here, we report the successful use of double LTx (DLTx)
to treat a 49-year-old patient with end-stage KS.
Case presentation
A 49-year-old Han woman was admitted to Renmin
Hospital of Wuhan University (Hubei, China) on
September 8, 2017. She had a ≥15 year history of chronic
bronchiectasis with chest discomfort, productive cough and
expectoration and had been treated with intranasal steroids
and antibiotics for suspected diagnoses of chronic sinusitis
and recurrent pneumonia. During the past year, her cough
had exacerbated with the production of copious purulent
sputum, and she underwent an 8-month course of therapy
for suspected smear-negative pulmonary tuberculosis. The
patient was a homemaker living in the countryside and had
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Figure 1 Imaging shows situs inversus and lung infection. (A) Anteroposterior chest X-ray showing dextrocardia; (B) chest CT showing
bilateral lower lung bronchiectasis with infection; (C) abdominal CT showing situs inversus.

never smoked cigarettes. There were no similar illnesses
in her family. This study was conducted in full accordance
with ethical principles (World Medical Association
Declaration of Helsinki, and the Declaration of Istanbul)
and was approved by ethics committee of Renmin Hospital
of Wuhan University.
Physical examination revealed the following: weight,
54 kg; body mass index, 18.6 kg/m 2 ; blood pressure,
91/60 mmHg; pulse rate, 109 beats/minute; respiratory rate,
20 breaths/minute; temperature, 36.8 ℃; and arterial oxygen
saturation (room air), 86%. There were coarse crackles and
scattered rhonchi over both basal lung fields. The cardiac
apex beat was palpable in the right fifth intercostal space
along the midclavicular line, and heart sounds were best
heard on the right side of the chest. Abdominal examination
revealed a tympanitic note on percussion and no sign of
fluid collection. The patient did not have any dyskinesia.
Nervous system examination was unremarkable.
Laboratory investigations revealed normal values for
hemoglobin (105 g/L), leukocyte count (5.97×109/L; 74%
granulocytes and 16.4% lymphocytes), platelet count
(130×109/L), and serum biochemistry tests. The patient
had chronic airway colonization with Gram-negative
bacteria but was negative for human immunodeficiency
virus and mycobacterium tuberculosis (sputum test for acid
fast bacilli). Arterial blood gas analysis revealed oxygendependent respiratory failure and hypercapnia (PO 2 ,
52 mmHg; PCO2, 82 mmHg; base excess, 19 mmol/L) that
required 24-hour oxygen support.
Anteroposterior chest radiography revealed a right-sided
cardiac apex and aortic arch (Figure 1A). Echocardiography
demonstrated dextrocardia and a pulmonary artery
systolic pressure of 49 mmHg. High-resolution computed
tomography (CT) of the chest showed bronchiectasis and
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fibrotic bands in both lower lung fields with no obvious
lymph nodes in the mediastinum (Figure 1B). Abdominal
CT showed a left-sided liver and inferior vena cava and a
right-sided spleen, suggesting situs inversus (Figure 1C).
Exome sequencing revealed mutations in the HEATR,
DNAH1, DNAH5, DNAHI1, DNAH9, DNAI2 and
DNAAF3 genes (Table 1). A diagnosis of KS was made based
on the clinical findings (4,6).
The patient’s symptoms were partially relieved
after several courses of antibiotics, oral steroids and
bronchodilators but recurred after therapy was discontinued.
The patient fulfilled the criteria for DLTx (5) and so was
evaluated at our hospital for LTx. The measured/predicted
recipient total lung capacity was 3.78/3.51 L (ratio: 1.08).
After 6 months on the waiting list (March 31, 2018), a
suitable donor was allocated by Chinese Donor Allocation
System COTAS with the following characteristics: 32-yearold male; weight, 58 kg; height, 156 cm; matching blood
type; clear chest radiograph; no history of smoking, brain
trauma or malignancy; and PaO2/FiO2 ratio of 563 mmHg.
The planned surgery was bilateral lung transplantation via
bilateral anterolateral thoracotomy without the use of central
extracorporeal membrane oxygenation (because our patient
had a pulmonary artery systolic pressure of 28 mmHg). Left
lung transplantation was performed first with an ischemic
time of 132 min followed by right lung transplantation with
an ischemic time of 224 min. An inadequate donor left atrial
cuff due to technical errors at the time of procurement was
evident during right lung transplantation. A partial patch
repair with donor aorta remnant was performed, and the
reconstruction was carried out using a 5-0 polypropylene
running suture. Care was taken not to stretch or twist the
pulmonary venous anastomosis (Figure 2A,B). All vascular
anastomoses were carefully inspected to detect any tension,
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Table 1 Exome sequencing results
Gene name

AAChange.refGene

HEATR1

HEATR1:NM_018072:exon8:c.A1043G:p.H348R

DNAH1

DNAH1:NM_015512:exon72:c.A11495G:p.H3832R

DNAH5

DNAH5:NM_001369:exon13:c.A1672G:p.T558A

DNAH5

DNAH5:NM_001369:exon2:c.G71A:p.G24E

DNAH5

DNAH5:NM_001369:exonl:c.T36G:p.H12Q

DNAH11

DNAH11:NM_001277115:exon64:c.G10399A:p.A3467T

DNAH9

DNAH9:NM_001372:exon32:c.G6485A:p.R2162K

DNAH9

DNAH9:NM_004662:exon14:c.G2058A:p.M686I,DNAH9:NM_001372:exon68: c.G13122A;p.M4374I

DNAI2

DNAI2:NM_0011728 10:exon12:c.G1636A:p.A546T,DNAI2:NM_023036:exon12:c.G1672A:pA558T

DNAAF3

DNAAF3:NM_001256714:exon10:c.G1294A:p.D432N, DNAAF3:NM_001256715:exon10:c.G1093A:p.D365N,
DNAAF3:NM_001256716:exon10:c.G93 1A:p.D31IN, DNAAF3:NM_178837:exon10:c.G1234A:p.D412N

A

B

Figure 2 The procedures of repairing and reconstructing an inadequate left cuff during lung transplantation. (A) A donor aorta patch was
used to repair and reconstruct an inadequate left cuff during surgery; (B) left atrium after intraoperative anastomoses.

kinking, narrowing or bleeding.
The patient was discharged to the intensive care unit and
extubated on postoperative day 2. For immunosuppression,
she received a standard triple regimen for 3 days (tacrolimus
0.1 mg/kg PO bid, mycophenolate mofetil 1 g IV bid, and
methylprednisolone 0.5 mg/kg IV qd) followed by oral
prednisone from day 4 (0.5 mg/kg PO qd, tapering down
by 5 mg/week to 0.25 mg/kg/day). Pseudomonas aeruginosa
and methicillin-resistant Staphylococcus aureus, which were
isolated from bronchoalveolar secretions obtained during
bronchoscopy, were treated according to the antimicrobial

© Journal of Thoracic Disease. All rights reserved.

resistance data and current guidelines. The patient
recovered well and was discharged on postoperative day 18.
The patient was followed-up 21 months after
transplantation. Her symptoms of cough and purulent
sputum were relieved. At the last follow-up, the patient
was doing well and was able to engage in her usual daily
activities. Bronchoscopy was done 18 months after
transplantation, which demonstrated a clear anastomotic
airway without excessive granulation tissue, bronchomalacia,
airway stenosis or fistula, and the anastomotic site showed no
evidence of mucosal necrosis or sloughing (Figure 3A,B,C).
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Figure 3 Bronchoscopy demonstrated a clear anastomotic airway.

Based on the physical examination and investigations, this
patient was diagnosed to suffer from end-stage KS. Antibiotics,
oral steroids and bronchodilators were administered which
partially relieved the patient’s symptoms. However, because
of the end-stage bronchiectasis secondary to KS, double
lung transplantation (DLTx) was eventually performed with
satisfactory outcomes up to 21 months follow-up.
iMDT discussion
Discussion among physicians from the Wuhan University
of Renmin Hospital
Ciliary dysfunction is the underlying cause of KS (2).
Impaired ciliary motility during embryogenesis
predisposes to left-right laterality defects such as situs
solitus (dextrocardia only) or situs inversus totalis (with
transpositions of thoracic and abdominal organs). In
addition to detrimental effects in the respiratory system,
impaired ciliary motility can cause infertility secondary to
sperm tail and fallopian tube dysfunction (3,6).
There are no curative treatments for KS. The main
therapeutic measures for early-stage KS are daily chest
physiotherapy, inhaled bronchodilators, vaccinations and
antibiotics. For end-stage KS, LTx may be useful. The
first heart and lung transplantation for KS (a 25-year-old
woman with a history of recurrent pulmonary infection)
was described in 1992 (7). Successful left LTx for KS was
described 2 years later (8), but only a few additional case
reports have been published since then, emphasizing the
challenges of LTx in patients with KS. Up to 2016, 28
patients with PCD or KS had undergone LTx in the USA,
and their 1-year survival was comparable to that of patients
with idiopathic pulmonary fibrosis, cystic fibrosis or chronic
obstructive pulmonary disease (9). Surgical management
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of KS has been described for 2 cases in China, one treated
with lobectomy and the other with LTx (10).
Very few case reports have described DLTx in patients
with KS. The configuration and length of the main stem
bronchi are inverted in patients with situs inversus, but
no technical modifications for the different anatomic
relationships were required in our case. The midline position
of the left atrium and pulmonary artery allowed anastomoses
with the recipient’s structures to be made as in patients with
situs solitus. Previous publications have emphasized the
potential anatomical conflict between the donor’s right lower
lobe and the recipient’s dextrocardia, although lung volume
reduction surgery was not necessary (8,11,12). However, in a
previous case in China, right lower lobectomy was required
during LTx because the volume of the right donor lung was
larger than that of the recipient (10). In our patient, different
bronchial angulation was not an obstacle, and airway
continuity was reestablished with end-to-end anastomoses
without the need for lung volume reduction (Figure 4).
There are some questions for further discussion.
Question 1: is there any difference between KS and
normal patients in the procedure of DLTx?
Expert opinion 1: Dr. Daniel Kreisel
We have recently reported the case of double lung
transplantation in a patient with Kartagener syndrome
and described technical modifications to account for the
anatomical variations in these patients (13). Since these
patients have a long right mainstem bronchus and a short
left mainstem bronchus, a right-sided double lumen
endotracheal tube was used for our procedure that was
placed in the anatomic right mainstem bronchus. Some
technical modifications were required for the vascular
anastomoses. The recipient left pulmonary artery was
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Figure 4 Image of the reconstructed pulmonary vessels and bronchi obtained 5 months after surgery.

located anterior to the bronchus while the donor left
pulmonary artery was located superior to the bronchus.
An end-to-end anastomosis between donor and recipient
pulmonary arteries was facilitated by mobilizing the
recipient pulmonary artery and transposing it to an
epibronchial position. In addition, we beveled the donor
pulmonary artery to optimize the orientation of the end-toend anastomosis. We found that the right donor pulmonary
artery needed to be adequately mobilized to account for a
relatively short right pulmonary artery in the recipient. In
our experience, no technical modifications were required for
the bronchial or venous anastomoses. While reports exist
that the size of the right lung graft needs to be reduced due
to space limitations of the right chest cavity in the recipient,
we did not find this necessary in our case.
Expert opinion 2: Dr. Jose Luis J. Danguilan
Yes, there is a difference in double lung transplantation in
patients with Kartagener’s syndrome specially in those with
anatomical variations like pulmonary situs inversus and
dextrocardia (13). A right-sided double-lumen endotracheal
tube was useful in the performance of pneumonectomy of
the anatomic left lung with division of the short recipient
left main bronchus (8,14).
A right lower lobectomy was required after implantation
due to the right-sided heart interfering with lung
expansion (14) although no technical modifications for the
different anatomic relationships were necessary in a DLTx
performed in a 46-year-old KS patient and discrepancies of
the bronchial lumina were easily overcome (12).
Furthermore, a detailed preoperative anatomical study
using multidetector row computed tomography (MDCT)
with 3D reconstruction should be undertaken by the lung
transplant team especially in patients with KS considering
variations in anatomy (15).
Expert opinion 3: Dr. Michael Hsin
Since 1995, the Queen Mary Hospital Cardiothoracic Surgery
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Hospital Lung Transplant Program has performed two cases
of double lung transplant for Kartagener’s syndrome, with one
case in 2015 and the other case in 2019.The case from 2015
was performed entirely with intraoperative ECMO support.
For the more recent case, the left donor lung implantation
was done without ECMO. When it came to the right side
donor lung implantation, to achieve the necessary exposure
the amount of retraction on the heart (because of dextrocardia)
required intraoperative ECMO support.
For the case done in 2015, because of excessive size
mismatch, lung volume reduction was required from
the right middle lobe and the lingula. No lung volume
reduction was needed for the case done in 2019. Similar to
the current case report from the Wuhan group, there were
no special modifications of the surgical technique for any of
the anastomoses in either of the two cases from the Queen
Mary Hospital. Both cases had uneventful operations and
early post-operative recovery.
A recent case report from the St Louis group (13) did
focus on the technical considerations in Kartagener’s
syndrome. They pointed out the following:
(I) An initial attempt to use a standard left-sided
double lumen endotracheal tube was unsatisfactory,
and had to switch to using a right-sided double
lumen endotracheal tube;
(II) For the recipient’s left pulmonary artery (PA)
anastomosis, they noted that the recipient’s PA had a
prebronchial position (i.e., anterior to the bronchus),
whereas the donor PA had an epibronchial (superior
to bronchus) location. The authors explained that
they had to adequately mobilize the PA for both
donor and recipient, and they had to divide the PA at
a bevel for size and orientation matching.
Another earlier report from the Brigham and Women’s
hospital described the use of an end-to side anastomosis to
deal with the issue of left PA anastomosis (8). In order to
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avoid distortion of the PA, the recipient left PA was divided
just beyond the origin of the truncus anterior, and the
stump was oversewn. The donor PA was the anastomosed
to the recipient at the origin of the truncus anterior.
Although no kinking of the PA was encountered, the
authors did mention that in postoperative angiogram, they
noted variable pressure in the area of the anastomosis,
suggesting turbulence of the pulmonary artery blood flow.
Indeed, Gauthier et al. (13) commented that they did not
use the end-to side anastomosis because of their concern
regarding the risk of stasis in the PA arterial stump of the
recipient PA.
Question 2: when the KS patient should consider about
the surgery?
Expert opinion 1: Dr. Daniel Kreisel
Criteria to refer patients with Kartagener syndrome for
lung transplantation generally resemble those for other
patients, who suffer from bronchiectatic diseases such as
cystic fibrosis. These criteria include forced expiratory
volume in 1 second (FEV1) ≤25% predicted, hypercapnia,
pulmonary hypertension and frequent exacerbations.
Expert opinion 2: Dr. Jose Luis J. Danguilan
As with other indications for lung transplantation, the
patient with KS should be considered for transplantation
if they have end-stage lung disease brought about by
repeated infections and retained airway secretions from
bronchiectasis for which maximal medical management and
conventional lung resections would be futile. DLTx has
been described for generalized bronchiectasis (16).
Expert opinion 3: Dr. Michael Hsin
Patients with Kartagener’s syndrome have primary
ciliary dyskinesia (PCD), and the accumulation of airway
secretions cause recurrent infections, eventually manifesting
as bronchiectasis. In a minority of patients, this progresses
to end-stage bronchiectasis. As pointed by the authors of
this manuscript, there are only a handful of publications
regarding lung transplantation in KS. Indeed, even for
non-cystic fibrosis bronchiectasis, there is not a lot of
published data available. However, the indicators of endstage lung disease in general bronchiectasis as outlined by
Hayes et al can be useful as points of reference (9). These are:
post-bronchodilator FEV1 <30%; exacerbation of pulmonary
disease needing intensive care stay; increasing frequency of
exacerbation needing intravenous antibiotics; refractory and/or
recurrent pneumothorax; recurrent hemoptysis not controlled
by embolization; other factors to consider include hypercarbia,
rapidly declining lung function, and resting hypoxemia.

© Journal of Thoracic Disease. All rights reserved.

Question 3: what about the survival outcomes for the
KS patients with DLTx?
Expert opinion 1: Dr. Daniel Kreisel
Lung transplantation for Kartagener syndrome is rare. A
review of the United Network for Organ Sharing registry
showed that 12 bilateral lung transplants have been
performed between 1987 and 2015 (9). The 1-year and
5-year survival rates after bilateral lung transplantation
for Kartagener syndrome patients were 74% and 65%,
respectively. Of note, no statistically significant differences
existed between the survival rates after lung transplantation
for Kartagener syndrome and lung transplantation for other
conditions such as idiopathic pulmonary fibrosis, cystic
fibrosis or chronic obstructive pulmonary disease.
Expert opinion 2: Dr. Jose Luis J. Danguilan
Since only a few patients with KS have undergone lung
transplantation since 1987 (9), it would be difficult to
accurately predict factors leading to long-term survival
in this subset of patients. However, it is safe to say that
lung transplantation markedly improves lung function and
exercise tolerance but post-transplantation survival depends
on the development of chronic lung allograft dysfunction
(CLAD) (17).
Expert opinion 3: Dr. Michael Hsin
As stated in this manuscript, the study from Hayes et al.
which queried the UNOS database between 1987-2015 on
Kartagener’s syndrome, the long term outcome after LTx is
comparable to the general LTx population (9). Specifically,
when compared to idiopathic pulmonary fibrosis (IPF),
cystic fibrosis (CF) and chronic obstructive pulmonary
disease (COPD) recipients, using Cox proportional hazards
regression, there were no differences in survival between KS
group and these groups. Nor was there any significant survival
advantage between KS group and these groups at one- year
post lung transplant (9). Interestingly, the authors also looked
at patients with PCD (impaired mucociliary clearance without
situs inversus and chronic sinusitis). Whilst comparisons of
overall survival between PCD and IPF, CF and COPD showed
no difference, at one- year post transplant, there was survival
advantage for CF and COPD relative to PCD.
Conclusions
In summary, we have reported the successful use of DLTx
to treat a patient with end-stage KS and respiratory
insufficiency. DLTx may be a feasible therapeutic option for
controlling symptoms and achieving long term survival in
patients with end-stage KS.
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